KeyBanc initiated coverage of RadNet (RDNT) with an Overweight rating and $92 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RDNT:
- RadNet acquires Radiology Regional, terms not disclosed
- RadNet names Mital Patel as COO, announces expanded executive roles
- Oncology Institute appoints Mark Stolper to board of directors
- RadNet’s Strategic Growth and AI Success Justify Buy Rating Despite Concerns
- RadNet short report points already known and disclosed, says Raymond James